(Post-pandemic Era)-Global The Irbesartan Market Segment Research Report 2023

Report ID: 875344 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Irbesartan Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Irbesartan Market by Value
      2.2.1 Global The Irbesartan Revenue by Type
      2.2.2 Global The Irbesartan Market by Value (%)
    2.3 Global The Irbesartan Market by Production
      2.3.1 Global The Irbesartan Production by Type
      2.3.2 Global The Irbesartan Market by Production (%)

3. The Major Driver of The Irbesartan Industry
    3.1 Historical & Forecast Global The Irbesartan Demand
    3.2 Largest Application for The Irbesartan (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Irbesartan Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Irbesartan Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Irbesartan Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Irbesartan Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Irbesartan Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Irbesartan Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Irbesartan Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Irbesartan Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Irbesartan Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Irbesartan Average Price Trend
    12.1 Market Price for Each Type of The Irbesartan in US (2017-2021)
    12.2 Market Price for Each Type of The Irbesartan in Europe (2017-2021)
    12.3 Market Price for Each Type of The Irbesartan in China (2017-2021)
    12.4 Market Price for Each Type of The Irbesartan in Japan (2017-2021)
    12.5 Market Price for Each Type of The Irbesartan in India (2017-2021)
    12.6 Market Price for Each Type of The Irbesartan in Korea (2017-2021)
    12.7 Market Price for Each Type of The Irbesartan in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Irbesartan Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Irbesartan

14. The Irbesartan Competitive Landscape
     14.1 Teva
        14.1.1 Teva Company Profiles
        14.1.2 Teva Product Introduction
        14.1.3 Teva The Irbesartan Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Taj Pharmaceuticals
        14.2.1 Taj Pharmaceuticals Company Profiles
        14.2.2 Taj Pharmaceuticals Product Introduction
        14.2.3 Taj Pharmaceuticals The Irbesartan Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Sumitomo Dainippon Pharma
        14.3.1 Sumitomo Dainippon Pharma Company Profiles
        14.3.2 Sumitomo Dainippon Pharma Product Introduction
        14.3.3 Sumitomo Dainippon Pharma The Irbesartan Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Sanofi
        14.4.1 Sanofi Company Profiles
        14.4.2 Sanofi Product Introduction
        14.4.3 Sanofi The Irbesartan Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Hanall
        14.5.1 Hanall Company Profiles
        14.5.2 Hanall Product Introduction
        14.5.3 Hanall The Irbesartan Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 BMS
        14.6.1 BMS Company Profiles
        14.6.2 BMS Product Introduction
        14.6.3 BMS The Irbesartan Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Jiangsu Hengrui Medicine
        14.7.1 Jiangsu Hengrui Medicine Company Profiles
        14.7.2 Jiangsu Hengrui Medicine Product Introduction
        14.7.3 Jiangsu Hengrui Medicine The Irbesartan Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Shionogi
        14.8.1 Shionogi Company Profiles
        14.8.2 Shionogi Product Introduction
        14.8.3 Shionogi The Irbesartan Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Novartis
        14.9.1 Novartis Company Profiles
        14.9.2 Novartis Product Introduction
        14.9.3 Novartis The Irbesartan Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Apotex
        14.10.1 Apotex Company Profiles
        14.10.2 Apotex Product Introduction
        14.10.3 Apotex The Irbesartan Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Zhuhai Rundu Pharma
     14.12 Tianjin Huairen Pharmaceutical
     14.13 Verdant Life Sciences
     14.14 Zhejiang Huahai Pharmaceutical
     14.15 Xiansheng Pharmaceutical
     14.16 Avanstra
     14.17 Angita Pharma
     14.18 Jiangsu Wangao Pharmaceutical
     14.19 CTTQ
     14.20 Auro Pharma
     14.21 Zhejiang Ainuo Pharmaceutical
     14.22 Yuanhe Pharmaceutical
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Irbesartan Industry (Volume)
    Figure 2. The Irbesartan Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Irbesartan Revenue in 2021
    Figure 5. US The Irbesartan Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Irbesartan Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Irbesartan Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Irbesartan Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Irbesartan Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Irbesartan Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Irbesartan Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Irbesartan Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Irbesartan Production, by Type (K Unit) (2017-2027)
    Table 5. The Irbesartan Demand (K Unit) by Application (2017-2027)
    Table 6. The Irbesartan Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Irbesartan Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Irbesartan Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Irbesartan in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Irbesartan in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Irbesartan in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Irbesartan in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Irbesartan in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Irbesartan in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Irbesartan in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Teva Profiles
    Table 61. Teva The Irbesartan Product Introduction
    Table 62. Teva The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Teva Strategic initiatives
    Table 64. Taj Pharmaceuticals Profiles
    Table 65. Taj Pharmaceuticals The Irbesartan Product Introduction
    Table 66. Taj Pharmaceuticals The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Taj Pharmaceuticals Strategic initiatives
    Table 68. Sumitomo Dainippon Pharma Profiles
    Table 69. Sumitomo Dainippon Pharma The Irbesartan Product Introduction
    Table 70. Sumitomo Dainippon Pharma The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Sumitomo Dainippon Pharma Strategic initiatives
    Table 72. Sanofi Profiles
    Table 73. Sanofi The Irbesartan Product Introduction
    Table 74. Sanofi The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Sanofi Strategic initiatives
    Table 76. Hanall Profiles
    Table 77. Hanall The Irbesartan Product Introduction
    Table 78. Hanall The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Hanall Strategic initiatives
    Table 80. BMS Profiles
    Table 81. BMS The Irbesartan Product Introduction
    Table 82. BMS The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. BMS Strategic initiatives
    Table 84. Jiangsu Hengrui Medicine Profiles
    Table 85. Jiangsu Hengrui Medicine The Irbesartan Product Introduction
    Table 86. Jiangsu Hengrui Medicine The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Jiangsu Hengrui Medicine Strategic initiatives
    Table 88. Shionogi Profiles
    Table 89. Shionogi The Irbesartan Product Introduction
    Table 90. Shionogi The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Shionogi Strategic initiatives
    Table 92. Novartis Profiles
    Table 93. Novartis The Irbesartan Product Introduction
    Table 94. Novartis The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Novartis Strategic initiatives
    Table 97. Apotex Profiles
    Table 98. Apotex The Irbesartan Product Introduction
    Table 99. Apotex The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Apotex Strategic initiatives
    Table 101. Zhuhai Rundu Pharma Profiles
    Table 102. Zhuhai Rundu Pharma The Irbesartan Product Introduction
    Table 103. Zhuhai Rundu Pharma The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Zhuhai Rundu Pharma Strategic initiatives
    Table 105. Tianjin Huairen Pharmaceutical Profiles
    Table 106. Tianjin Huairen Pharmaceutical The Irbesartan Product Introduction
    Table 107. Tianjin Huairen Pharmaceutical The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Tianjin Huairen Pharmaceutical Strategic initiatives
    Table 109. Verdant Life Sciences Profiles
    Table 110. Verdant Life Sciences The Irbesartan Product Introduction
    Table 111. Verdant Life Sciences The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. Verdant Life Sciences Strategic initiatives
    Table 113. Zhejiang Huahai Pharmaceutical Profiles
    Table 114. Zhejiang Huahai Pharmaceutical The Irbesartan Product Introduction
    Table 115. Zhejiang Huahai Pharmaceutical The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 116. Zhejiang Huahai Pharmaceutical Strategic initiatives
    Table 117. Xiansheng Pharmaceutical Profiles
    Table 118. Xiansheng Pharmaceutical The Irbesartan Product Introduction
    Table 119. Xiansheng Pharmaceutical The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 120. Xiansheng Pharmaceutical Strategic initiatives
    Table 121. Avanstra Profiles
    Table 122. Avanstra The Irbesartan Product Introduction
    Table 123. Avanstra The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 124. Avanstra Strategic initiatives
    Table 125. Angita Pharma Profiles
    Table 126. Angita Pharma The Irbesartan Product Introduction
    Table 127. Angita Pharma The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 128. Angita Pharma Strategic initiatives
    Table 129. Jiangsu Wangao Pharmaceutical Profiles
    Table 130. Jiangsu Wangao Pharmaceutical The Irbesartan Product Introduction
    Table 131. Jiangsu Wangao Pharmaceutical The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 132. Jiangsu Wangao Pharmaceutical Strategic initiatives
    Table 133. CTTQ Profiles
    Table 134. CTTQ The Irbesartan Product Introduction
    Table 135. CTTQ The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 136. CTTQ Strategic initiatives
    Table 137. Auro Pharma Profiles
    Table 138. Auro Pharma The Irbesartan Product Introduction
    Table 139. Auro Pharma The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 140. Auro Pharma Strategic initiatives
    Table 141. Zhejiang Ainuo Pharmaceutical Profiles
    Table 142. Zhejiang Ainuo Pharmaceutical The Irbesartan Product Introduction
    Table 143. Zhejiang Ainuo Pharmaceutical The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 144. Zhejiang Ainuo Pharmaceutical Strategic initiatives
    Table 145. Yuanhe Pharmaceutical Profiles
    Table 146. Yuanhe Pharmaceutical The Irbesartan Product Introduction
    Table 147. Yuanhe Pharmaceutical The Irbesartan Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Irbesartan Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Irbesartan Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Irbesartan Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports